BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 31568705)

  • 1. Fecal occult blood test screening uptake among immigrants from Muslim majority countries: A retrospective cohort study in Ontario, Canada.
    Vahabi M; Lofters A; Wong JP; Ellison L; Graves E; Damba C; Glazier RH
    Cancer Med; 2019 Nov; 8(16):7108-7122. PubMed ID: 31568705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer screening utilization among women from Muslim majority countries in Ontario, Canada.
    Vahabi M; Lofters A; Kim E; Wong JP; Ellison L; Graves E; Glazier RH
    Prev Med; 2017 Dec; 105():176-183. PubMed ID: 28916289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of non-adherence to colorectal cancer screening among immigrants to Ontario, Canada: a population-based study.
    Shen SC; Lofters A; Tinmouth J; Paszat L; Rabeneck L; Glazier RH
    Prev Med; 2018 Jun; 111():180-189. PubMed ID: 29548788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical Cancer Screening among Women from Muslim-Majority Countries in Ontario, Canada.
    Lofters AK; Vahabi M; Kim E; Ellison L; Graves E; Glazier RH
    Cancer Epidemiol Biomarkers Prev; 2017 Oct; 26(10):1493-1499. PubMed ID: 28939586
    [No Abstract]   [Full Text] [Related]  

  • 5. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
    Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
    Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care physician characteristics associated with cancer screening: a retrospective cohort study in Ontario, Canada.
    Lofters AK; Ng R; Lobb R
    Cancer Med; 2015 Feb; 4(2):212-23. PubMed ID: 25430885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact on immigrant screening adherence with introduction of a population-based colon screening program in Ontario, Canada.
    Moustaqim-Barrette A; Spinelli JJ; Kazanjian A; Dummer TJB
    Cancer Med; 2019 Apr; 8(4):1826-1834. PubMed ID: 30791219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of breast and colorectal cancer among immigrants in Ontario, Canada: a retrospective cohort study from 2004-2014.
    Shuldiner J; Liu Y; Lofters A
    BMC Cancer; 2018 May; 18(1):537. PubMed ID: 29739346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening disparities among urban immigrants: a population-based study in Ontario, Canada.
    Vahabi M; Lofters A; Kumar M; Glazier RH
    BMC Public Health; 2015 Jul; 15():679. PubMed ID: 26194189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer screening disparities among immigrant women by world region of origin: a population-based study in Ontario, Canada.
    Vahabi M; Lofters A; Kumar M; Glazier RH
    Cancer Med; 2016 Jul; 5(7):1670-86. PubMed ID: 27105926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of low cervical cancer screening among immigrant women in Ontario, Canada.
    Lofters AK; Moineddin R; Hwang SW; Glazier RH
    BMC Womens Health; 2011 May; 11():20. PubMed ID: 21619609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equity and practice issues in colorectal cancer screening: Mixed-methods study.
    Buchman S; Rozmovits L; Glazier RH
    Can Fam Physician; 2016 Apr; 62(4):e186-93. PubMed ID: 27618142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study.
    Hategekimana C; Karamouzian M
    Int J Health Policy Manag; 2016 Feb; 5(6):365-71. PubMed ID: 27285514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the impact of public health initiatives on trends in fecal occult blood test participation in Ontario.
    Honein-AbouHaidar GN; Rabeneck L; Paszat LF; Sutradhar R; Tinmouth J; Baxter NN
    BMC Cancer; 2014 Jul; 14():537. PubMed ID: 25062552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response.
    Tinmouth J; Baxter NN; Paszat LF; Rabeneck L; Sutradhar R; Yun L
    BMJ Open; 2014 Mar; 4(3):e004494. PubMed ID: 24622950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
    Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.